EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...
More for You More Than 90 Republicans Targeted in ‘Arctic Frost’ Scientists Studied 'SuperAgers' For 25 Years And Found That They All Have This 1 Habit In Common Dodgers' Shohei Ohtani snaps 50-year ...
The use of automated insulin delivery systems (AID) is standard of care for people with type 1 diabetes. However, the limited capacity of insulin pump cartridges, which can hold 1.6-3.0mL or the ...
The state’s CalRx Insulin Glargine will be available to consumers for a suggested retail price of $55 or less per five-pack of pens beginning Jan. 1, 2026. The insulin glargine pen agreement with ...
Share on Pinterest Experts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and sell lower-cost ...
Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable insulin pen ended with an anticlimax Monday. The order formally dismissing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback